Vanguard Group
ACOR

Vanguard Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,260
Closed -$254K 4519
2024
Q1
$254K Buy
19,260
+8,452
+78% +$112K ﹤0.01% 4140
2023
Q4
$163K Buy
10,808
+74
+0.7% +$1.12K ﹤0.01% 4248
2023
Q3
$161K Buy
+10,734
New +$161K ﹤0.01% 4288
2023
Q2
Sell
-159,778
Closed -$93.6K 4598
2023
Q1
$93.6K Buy
159,778
+1,459
+0.9% +$855 ﹤0.01% 4414
2022
Q4
$121K Buy
158,319
+3,040
+2% +$2.33K ﹤0.01% 4372
2022
Q3
$46K Sell
155,279
-2,782
-2% -$824 ﹤0.01% 4550
2022
Q2
$73K Sell
158,061
-183,484
-54% -$84.7K ﹤0.01% 4566
2022
Q1
$549K Hold
341,545
﹤0.01% 4384
2021
Q4
$817K Hold
341,545
﹤0.01% 4316
2021
Q3
$1.57M Buy
341,545
+1,064
+0.3% +$4.89K ﹤0.01% 4130
2021
Q2
$1.62M Buy
340,481
+68,240
+25% +$325K ﹤0.01% 4031
2021
Q1
$1.33M Sell
272,241
-1,547,888
-85% -$7.53M ﹤0.01% 3949
2020
Q4
$1.26M Sell
1,820,129
-1,042,304
-36% -$719K ﹤0.01% 3773
2020
Q3
$1.47M Sell
2,862,433
-1,145,314
-29% -$590K ﹤0.01% 3575
2020
Q2
$2.94M Sell
4,007,747
-423,251
-10% -$311K ﹤0.01% 3318
2020
Q1
$4.14M Sell
4,430,998
-612,640
-12% -$572K ﹤0.01% 3051
2019
Q4
$10.3M Sell
5,043,638
-932,599
-16% -$1.9M ﹤0.01% 2845
2019
Q3
$17.2M Sell
5,976,237
-216,034
-3% -$620K ﹤0.01% 2557
2019
Q2
$47.5M Sell
6,192,271
-677,091
-10% -$5.19M ﹤0.01% 2127
2019
Q1
$91.3M Buy
6,869,362
+766,007
+13% +$10.2M ﹤0.01% 1795
2018
Q4
$95.1M Buy
6,103,355
+718,819
+13% +$11.2M ﹤0.01% 1706
2018
Q3
$106M Buy
5,384,536
+545,689
+11% +$10.7M ﹤0.01% 1775
2018
Q2
$139M Buy
4,838,847
+450,659
+10% +$12.9M 0.01% 1595
2018
Q1
$104M Buy
4,388,188
+11,599
+0.3% +$274K ﹤0.01% 1695
2017
Q4
$93.9M Buy
4,376,589
+116,531
+3% +$2.5M ﹤0.01% 1752
2017
Q3
$101M Sell
4,260,058
-48,102
-1% -$1.14M ﹤0.01% 1712
2017
Q2
$84.9M Buy
4,308,160
+168,571
+4% +$3.32M ﹤0.01% 1763
2017
Q1
$86.9M Buy
4,139,589
+233,575
+6% +$4.91M ﹤0.01% 1739
2016
Q4
$73.4M Sell
3,906,014
-116,740
-3% -$2.19M ﹤0.01% 1790
2016
Q3
$84M Sell
4,022,754
-245,925
-6% -$5.13M ﹤0.01% 1676
2016
Q2
$109M Buy
4,268,679
+759,257
+22% +$19.4M 0.01% 1462
2016
Q1
$92.8M Buy
3,509,422
+225,649
+7% +$5.97M 0.01% 1535
2015
Q4
$140M Buy
3,283,773
+89,986
+3% +$3.85M 0.01% 1228
2015
Q3
$84.7M Buy
3,193,787
+78,398
+3% +$2.08M 0.01% 1555
2015
Q2
$104M Buy
3,115,389
+129,614
+4% +$4.32M 0.01% 1496
2015
Q1
$99.4M Buy
2,985,775
+142,562
+5% +$4.74M 0.01% 1499
2014
Q4
$116M Buy
2,843,213
+15,589
+0.6% +$637K 0.01% 1309
2014
Q3
$95.8M Buy
2,827,624
+45,705
+2% +$1.55M 0.01% 1386
2014
Q2
$93.8M Buy
2,781,919
+8,778
+0.3% +$296K 0.01% 1438
2014
Q1
$105M Buy
2,773,141
+117,545
+4% +$4.46M 0.01% 1319
2013
Q4
$77.5M Buy
2,655,596
+127,206
+5% +$3.71M 0.01% 1487
2013
Q3
$86.7M Buy
2,528,390
+75,277
+3% +$2.58M 0.01% 1337
2013
Q2
$80.9M Buy
+2,453,113
New +$80.9M 0.01% 1309